Our research is part of scientifically important work at Hadassah into the delivery of stem cells for M.S. This is alongside other techniques, including drug advancement and early and correct diagnosis of the disease has huge imoplications for degenerative brain diseases.
Hadassah's collaborative approach to M.S. links up with other specialists in the overall treatment of M.S. and researching a new technique to deliver stem cells directly to the Central Nervous System via the spinal cord.
This is a research area where the "best of Israel" - one of the most technologically advanced countries in the world - will soon impact patients around the world.
We at Hadassah hope to support Israeli research in a meaningful cost-effective way, and make a real difference to Multiple Sclerosis sufferers - including those in the U.K.
“Intrathecal stem cells are the clearest way to go and the method of delivery of Prof Karussis’s trial is key for MS & other degenerative diseases… This is the future.” - Dr. A. Coxon
Our research is part of scientifically important work at Hadassah into the delivery of stem cells for MS. This, alongside other techniques, including drug advancement and the correct diagnosis and evolution of the disease, has huge implications for degenerative brain diseases.
Hadassah is now recommending more treatment for the early stages of MS, (the first 1-5 years) and also the later progressive stages. Hadassah has a collaborative approach to MS treatment, linking up with other specialists in the overall treatment of MS.
Trials are now taking place in 30 centres worldwide, however this is the only clinical research centre in the world doing this work in a human trial delivering stem cells directly into the Central Nervous System through the spinal cord.